Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Su-Zhen Li"'
Autor:
Su ZL; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Hang PZ; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China.; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150081, China., Hu J; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Zheng YY; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Sun HQ; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Guo J; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Liu KY; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China., Du ZM; Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University (University Key Laboratory of Drug Research, Heilongjiang Province), Harbin, 150086, China. dzm1956@126.com.; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150081, China. dzm1956@126.com.; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, 999078, China. dzm1956@126.com.
Publikováno v:
Acta pharmacologica Sinica [Acta Pharmacol Sin] 2020 Aug; Vol. 41 (8), pp. 1085-1092. Date of Electronic Publication: 2020 Mar 18.
Autor:
Qing-shan, Shen, Yong-sheng, Liu, Rui, Zhu, Du-guan, Fu, Yong-qian, Tang, Hong, Tao, Su-zhen, Li, Jian-wen, Ye
Publikováno v:
Zhonghua xin xue guan bing za zhi. 33(4)
To investigate the effect of fluvastatin on blood levels of c-reactive protein (CRP), tumor necrosis factor alpha (TNFalpha) and cardiac troponin I (cTnI) in patients with unstable angina undergoing percutaneous coronary intervention (PCI).Sixty pati